TG Therapeutics | TGTX - Ebitda

Stock Price
28.64
Daily Change
-0.48 -1.65%
Monthly
-2.62%
Yearly
-14.51%
Q1 Forecast
28.52

TG Therapeutics reported $37.7M in EBITDA for its fiscal quarter ending in June of 2025.





Ebitda Change Date
AbbVie USD 3.52B 828M Sep/2025
Alaunos Therapeutics USD -21.02M 1.33M Mar/2021
Amgen USD 5.91B 2.31B Sep/2025
Ardelyx USD 5.57M 17.44M Sep/2025
Arrowhead Research USD 64.2M 223.53M Sep/2025
Bayer EUR 1.51B 1.28B Sep/2025
Biogen USD 1.01B 456.5M Jun/2025
Corcept Therapeutics USD 27.14M 23.27M Jun/2025
Dynavax Technologies USD 35.53M 10.9M Sep/2025
Gilead Sciences USD 4.03B 628M Sep/2025
J&J USD 9.52B 389M Sep/2025
Novartis USD 5.88B 290M Sep/2025
PTC Therapeutics USD -33.11M 1B Jun/2025
Regeneron Pharmaceuticals USD 1.92B 261.9M Sep/2025
Roche Holding CHF 12.68B 2.36B Jun/2024
TG Therapeutics USD 37.7M 25.41M Jun/2025
Vertex Pharmaceuticals USD 1.44B 100.4M Sep/2025